Laman UtamaPRQR • NASDAQ
add
ProQR Therapeutics NV
$2.15
Selepas Waktu Dagangan:(4.44%)+0.095
$2.25
Tutup: 30 Jan, 8:00:00 PTG GMT-5 · USD · NASDAQ · Penafian
Tutup sebelumnya
$1.99
Julat hari
$1.99 - $2.19
Julat tahun
$1.61 - $4.62
Permodalan pasaran
227.69J USD
Bilangan Purata
471.86K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (EUR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 3.98J | 190.58% |
Perbelanjaan pengendalian | 12.70J | 44.93% |
Pendapatan bersih | -8.11J | -42.00% |
Margin untung bersih | -203.67 | 51.13% |
Pendapatan bagi setiap syer | -0.08 | 0.41% |
EBITDA | -8.03J | -18.95% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (EUR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 89.40J | -25.84% |
Jumlah aset | 106.85J | -24.77% |
Jumlah liabiliti | 81.87J | -14.45% |
Jumlah ekuiti | 24.98J | — |
Syer tertunggak | 81.68J | — |
Harga kepada buku | 6.42 | — |
Pulangan pada aset | -19.38% | — |
Pulangan pada modal | -46.15% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (EUR) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -8.11J | -42.00% |
Tunai daripada operasi | -5.66J | 24.65% |
Tunai daripada pelaburan | 16.71J | 5,030.38% |
Tunai daripada pembiayaan | -453.00K | -61.21% |
Perubahan bersih dalam tunai | 10.43J | 230.22% |
Aliran tunai bebas | 743.50K | 156.44% |
Perihal
ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer. Wikipedia
Diasaskan
2012
Tapak web
Pekerja
157
